Eunji Nam

Eunji Nam

Auto-generated profile, based on publicly available information

Eunji Nam

Incheon National University, 119 Academy-ro Yeonsu-gu, Incheon, South Korea

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

13 September 2022 in Journal of Racial and Ethnic Health Disparities
Verified
Journal Article
Closed access
PDF file
MVMichelle M. Vance
Michelle M. Vance
KGKim Gryglewicz
Kim Gryglewicz
ENEunji Nam
Eunji Nam
SRSonyia Richardson
Sonyia Richardson
LBLisa Borntrager
Lisa Borntrager
MKMarc S. Karver
Marc S. Karver

19 February 2021 in Psychiatric Quarterly
Verified
Journal Article
Closed access
PDF file
ENEunji Nam
Eunji Nam
ELEunkyung Lee
Eunkyung Lee
HKHyemee Kim
Hyemee Kim

31 January 2022 in International Journal of Geriatric Psychiatry
Verified
Journal Article
Closed access
PDF file
SHSeok Cheol Ha
Seok Cheol Ha
ENEunji Nam
Eunji Nam

1 August 2021 in Journal of Adolescent Health
Verified
Journal Article
Closed access
ENEunji Nam
Eunji Nam
APAshley N. Palmer
Ashley N. Palmer
MPMansi Patel
Mansi Patel

12 November 2020 in JMIR Research Protocols
Verified
Journal Article
Open access
ELEunkyung Lee
Eunkyung Lee
RHRobert B Hines
Robert B Hines
JWJean L Wright
Jean L Wright
ENEunji Nam
Eunji Nam
MRMichael Rovito
Michael Rovito
XLXinliang Liu
Xinliang Liu
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: The National Comprehensive Cancer Network Breast Cancer Guidelines Committee has suggested that the omission of adjuvant radiation therapy (RT) after breast-conserving surgery can be a reasonable option among older women with low-risk breast cancer (early-stage, ER-positive, and node-negative) if they are treated with endocrine therapy. However, RT usage in this group of women still exceeds 50%. On the other hand, older women tend to forego RT (even when necessary) due to cost, inconvenience, and potential adverse responses associated with RT. Understanding health-related quality of life (HRQOL) change with receipt of RT among older women in the modern era is limited due to the underrepresentation of this population in clinical trials. Objective: The proposed study aims to examine the associations of RT with HRQOL trajectories as well as survival outcomes among older women over 5-10 year follow-up. We will also assess whether pre-diagnosis comorbidity burden influences receipt of RT and whether the associations between RT and HRQOL trajectory and survival outcomes are modified by comorbidity burden. Methods: We will use a retrospective cohort study design with the population-based database of Surveillance, Epidemiology, and End-Results linked to the Medicare Health Outcomes Survey (SEER-MHOS). Older women (65+) diagnosed with low-risk breast cancer in 1998-2014, received BCS, and participated in MHOS 1998-2016 are eligible for the current analysis. The clustering method, latent class analysis, will be used to identify each patient’s pre-diagnosis comorbidity burden, and HRQOL will be evaluated using SF-36/VR-12 scales. The inverse-weighted estimates of the probability of treatment will be included as a covariate to control for treatment selection bias and confounding effects in subsequent analysis. The association of RT with HRQOL trajectory will be evaluated using inverse-weighted semiparametric B-splines models. The inverse-weighted Cox regression model will be used to obtain hazard ratios with 95% confidence intervals for the association of RT with survival outcomes. Differential effects of RT on both outcomes according to comorbidity burden class will also be evaluated. Results: As of January 2020, the study was approved by the institutional review board, and the SEER-MHOS data was obtained from the National Cancer Institute and SEER. Women with low-risk breast cancer who met inclusion and exclusion criteria have been identified, and pre-diagnosis comorbidity burden has been characterized using latent class analysis. Further data analysis will begin in February 2020, and the first manuscript will be submitted in a peer-reviewed journal in June 2020. Conclusions: This research has the potential to improve clinical outcomes of older women with low-risk breast cancer by providing them additional information on the HRQOL trajectories when they make RT treatment-decision. It will facilitate informed, shared treatment decision and cancer care planning and ultimately will improve the HRQOL of older women with breast cancer. Clinical Trial: NA